Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Antiepileptics

FDA 2022

Other antiepileptics

Brivaracetam

Approved 20 Dec 2022OralTablet

The FDA lists this product in 49 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: BRIVARACETAM 100MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

BRIVARACETAM 100MG · TabletThis page
BRIVARACETAM 50MG · TabletANDA214918-003 · Discontinued
BRIVARACETAM 10MG · TabletANDA214918-001 · Discontinued
BRIVARACETAM 75MG · TabletANDA214918-004 · Discontinued
BRIVARACETAM 25MG · TabletANDA214918-002 · Discontinued
BRIVARACETAM 50MG/5ML (10MG/ML) · SolutionANDA218249-001 · Prescription
BRIVARACETAM 10MG/ML · SolutionANDA214922-001 · Prescription
BRIVARACETAM 100MG · TabletANDA214748-005 · Prescription
BRIVARACETAM 50MG · TabletANDA214748-003 · Prescription
BRIVARACETAM 10MG · TabletANDA214748-001 · Prescription
BRIVARACETAM 75MG · TabletANDA214748-004 · Prescription
BRIVARACETAM 25MG · TabletANDA214748-002 · Prescription

More in antiepileptics

Subvenitelamotrigine · Suspension

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

BRIVARACETAM 75mg · TabletANDA214831-004 · Tentative approval

BRIVARACETAM 25mg · TabletANDA214831-002 · Tentative approval

BRIVARACETAM 100mg · TabletANDA214831-005 · Tentative approval

BRIVARACETAM 50mg · TabletANDA214831-003 · Tentative approval

BRIVARACETAM 50MG/5ML (10MG/ML) · SolutionANDA214880-001 · Prescription

BRIVARACETAM 75MG · TabletANDA220470-004 · Prescription

BRIVARACETAM 25MG · TabletANDA220470-002 · Prescription

BRIVARACETAM 100MG · TabletANDA220470-005 · Prescription

BRIVARACETAM 50MG · TabletANDA220470-003 · Prescription

BRIVARACETAM 10MG · TabletANDA220470-001 · Prescription

BRIVARACETAM 100MG · TabletANDA219583-005 · Tentative approval

BRIVARACETAM 50MG · TabletANDA219583-003 · Tentative approval

BRIVARACETAM 10MG · TabletANDA219583-001 · Tentative approval

BRIVARACETAM 75MG · TabletANDA219583-004 · Tentative approval

BRIVARACETAM 25MG · TabletANDA219583-002 · Tentative approval

BRIVARACETAM 100MG · TabletANDA214921-005 · Prescription

BRIVARACETAM 50MG · TabletANDA214921-003 · Prescription

BRIVARACETAM 10MG · TabletANDA214921-001 · Prescription

BRIVARACETAM 75MG · TabletANDA214921-004 · Prescription

BRIVARACETAM 25MG · TabletANDA214921-002 · Prescription

BRIVARACETAM 10MG/ML · SolutionANDA218494-001 · Prescription

BRIVARACETAM 50MG · TabletANDA214848-001 · Prescription

BRIVARACETAM 100MG · TabletANDA214848-002 · Prescription

BRIVARACETAM 75MG · TabletANDA214875-004 · Prescription

BRIVARACETAM 25MG · TabletANDA214875-002 · Prescription

BRIVARACETAM 100MG · TabletANDA214875-005 · Prescription

BRIVARACETAM 50MG · TabletANDA214875-003 · Prescription

BRIVARACETAM 10MG · TabletANDA214875-001 · Prescription

BRIVARACETAM 100MG · TabletANDA214501-005 · Prescription

BRIVARACETAM 50MG · TabletANDA214501-003 · Prescription

BRIVARACETAM 10MG · TabletANDA214501-001 · Prescription

BRIVARACETAM 75MG · TabletANDA214501-004 · Prescription

BRIVARACETAM 25MG · TabletANDA214501-002 · Prescription

BRIVARACETAM 10MG/ML · SolutionANDA220385-001 · Prescription

BRIVARACETAM 50MG/5ML (10MG/ML) · SolutionANDA214924-001 · Prescription

BRIVARACETAM 10MG/ML · SolutionANDA219772-001 · Prescription

BRIVARACETAM 10MG/ML · SolutionANDA220164-001 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA214918.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Brivaracetam
Drug class: Other antiepileptics
Group: Antiepileptics
Route: Oral
Dosage form: Tablet
Applicant: Lupin
Status: Discontinued
FDA approval: 20 Dec 2022
Application: ANDA214918-005
RxCUI: 1739745

Guidelines

Guidelines in neurology608 guidelines in the library

FDA 2025

PerampanelSuspension

FDA 2023MethsuximideCapsule

FDA 2022LacosamideSolution

FDA 2021Eprontiatopiramate · Solution

FDA 2021PregabalinTablet, extended release

FDA 2020Sesquientfosphenytoin sodium · Solution

FDA 2019RufinamideSuspension

FDA 2019VigabatrinTablet

FDA 2018OxcarbazepineTablet, extended release

FDA 2018Vigadronevigabatrin · For solution

FDA 2017TopiramateCapsule, extended release

FDA 2013Trokendi XRtopiramate · Capsule, extended release

FDA 2013LamotrigineTablet, orally disintegrating

FDA 2012PhenytoinTablet, chewable

FDA 2011FelbamateSuspension